Key result
ECT yields rapid recovery from residual catatonia following neuroleptic malignant syndrome without mortality.
Why the study?
Does electroconvulsive therapy improve recovery in patients with residual catatonic state following neuroleptic malignant syndrome?
Case Report (n=32)
Does electroconvulsive therapy improve recovery in patients with residual catatonic state following neuroleptic malignant syndrome?
Answers are grounded in this paper and cite their sources.
ECT can be highly effective in treating the residual catatonic state that follows NMS, particularly in patients refractory to pharmacotherapy.
Neuroleptic malignant syndrome (NMS) is usually a self-limited disorder, with most cases resolving within 2 weeks after antipsychotic drug discontinuation. However, the course of NMS may not always be short-lived. In this report, the authors describe five patients who developed a residual catatonic state that persisted after acute hyperthermic symptoms of NMS had subsided and compare them with 27 similar cases in the literature. Two of our patients recovered gradually with supportive treatment. Three patients were treated with electroconvulsive therapy (ECT). Of these, two showed a positive response, although one died later of intercurrent pneumonia. A third patient did not respond to ECT, but recovered gradually thereafter. Although dopamine agonists or benzodiazepines have been advocated for the treatment of residual symptoms in previous case reports, ECT was the treatment most often associated with a rapid response and no mortality, even in patients refractory to pharmacotherapy. In conclusion, catatonic and parkinsonian symptoms of NMS may persist as a residual state lasting for weeks to months after more fulminant acute symptoms abate. These residual symptoms may be more likely to develop in patients with pre-existing structural brain disorders. Although patients may improve gradually with supportive care or pharmacotherapy, ECT can often be highly effective in treating the residual catatonic state that follows NMS.
No takes yet. Share an insight, caveat, or question.
Caroff et al. (2000) conducted a case report in Neuroleptic malignant syndrome (NMS) with residual catatonic state (n=32). Electroconvulsive therapy (ECT) vs. Supportive care or pharmacotherapy was evaluated on Recovery from residual catatonic state. Electroconvulsive therapy (ECT) was highly effective in treating the residual catatonic state following neuroleptic malignant syndrome, often yielding a rapid response without mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: